Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.098x

Based on the latest financial reports, Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) has a cash flow conversion efficiency ratio of 0.098x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs246.75 Million ≈ $2.67 Million USD) by net assets (Rs2.53 Billion ≈ $27.34 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See JAGSNPHARM equity financing ratio to measure how much of total assets are equity-financed.

Jagsonpal Pharmaceuticals Limited - Cash Flow Conversion Efficiency Trend (2006–2025)

This chart illustrates how Jagsonpal Pharmaceuticals Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check how high is Jagsonpal Pharmaceuticals Limited's earnings quality to evaluate the quality of earnings relative to operating cash generation.

Jagsonpal Pharmaceuticals Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Jagsonpal Pharmaceuticals Limited ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
HomesToLife Ltd
NASDAQ:HTLM
0.084x
Paninvest Tbk
JK:PNIN
0.018x
Arcturus Therapeutics Holdings Inc
NASDAQ:ARCT
-0.102x
TrueBlue Inc
NYSE:TBI
-0.038x
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3
0.247x
Jean Co Ltd
TW:2442
0.583x
MEDICLIN Aktiengesellschaft
XETRA:MED
0.097x
Hanyang Securities Co Ltd
KO:001755
3.040x

Annual Cash Flow Conversion Efficiency for Jagsonpal Pharmaceuticals Limited (2006–2025)

The table below shows the annual cash flow conversion efficiency of Jagsonpal Pharmaceuticals Limited from 2006 to 2025. For the full company profile with market capitalisation and key ratios, see JAGSNPHARM market cap.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-03-31 Rs2.40 Billion
≈ $25.95 Million
Rs553.00 Million
≈ $5.98 Million
0.230x +22.82%
2024-03-31 Rs1.87 Billion
≈ $20.27 Million
Rs351.66 Million
≈ $3.80 Million
0.188x -36.09%
2023-03-31 Rs1.59 Billion
≈ $17.18 Million
Rs466.54 Million
≈ $5.05 Million
0.294x +586.35%
2022-03-31 Rs1.31 Billion
≈ $14.15 Million
Rs55.98 Million
≈ $605.41K
0.043x -81.52%
2021-03-31 Rs1.22 Billion
≈ $13.19 Million
Rs282.22 Million
≈ $3.05 Million
0.231x +128.51%
2020-03-31 Rs1.11 Billion
≈ $12.01 Million
Rs112.47 Million
≈ $1.22 Million
0.101x -65.75%
2019-03-31 Rs1.04 Billion
≈ $11.30 Million
Rs308.98 Million
≈ $3.34 Million
0.296x +1940.07%
2018-03-31 Rs980.47 Million
≈ $10.60 Million
Rs-15.76 Million
≈ $-170.43K
-0.016x +45.50%
2017-03-31 Rs1.10 Billion
≈ $11.89 Million
Rs-32.41 Million
≈ $-350.56K
-0.029x -132.09%
2016-03-31 Rs983.64 Million
≈ $10.64 Million
Rs90.39 Million
≈ $977.48K
0.092x +104.01%
2015-03-31 Rs954.26 Million
≈ $10.32 Million
Rs42.98 Million
≈ $464.81K
0.045x -40.94%
2014-03-31 Rs985.89 Million
≈ $10.66 Million
Rs75.18 Million
≈ $813.08K
0.076x -37.74%
2013-03-31 Rs983.71 Million
≈ $10.64 Million
Rs120.50 Million
≈ $1.30 Million
0.122x +70.29%
2012-03-31 Rs984.69 Million
≈ $10.65 Million
Rs70.83 Million
≈ $766.00K
0.072x +3.52%
2011-03-31 Rs929.14 Million
≈ $10.05 Million
Rs64.56 Million
≈ $698.20K
0.069x +611.50%
2010-03-31 Rs875.70 Million
≈ $9.47 Million
Rs8.55 Million
≈ $92.49K
0.010x -95.61%
2009-03-31 Rs801.68 Million
≈ $8.67 Million
Rs178.16 Million
≈ $1.93 Million
0.222x +198.39%
2008-03-31 Rs750.34 Million
≈ $8.11 Million
Rs55.88 Million
≈ $604.33K
0.074x +127.99%
2007-03-31 Rs724.98 Million
≈ $7.84 Million
Rs23.68 Million
≈ $256.11K
0.033x +44.65%
2006-03-31 Rs702.35 Million
≈ $7.60 Million
Rs15.86 Million
≈ $171.53K
0.023x --

About Jagsonpal Pharmaceuticals Limited

NSE:JAGSNPHARM India Drug Manufacturers - Specialty & Generic
Market Cap
$170.27 Million
Rs15.74 Billion INR
Market Cap Rank
#17127 Global
#905 in India
Share Price
Rs235.37
Change (1 day)
+1.98%
52-Week Range
Rs161.07 - Rs278.35
All Time High
Rs761.20
About

Jagsonpal Pharmaceuticals Limited engages in the manufacturing, selling, and trading of pharmaceutical products and active pharmaceutical ingredients in India and internationally. It offers pharmaceutical formulations and products in the areas of gynaecology, orthopaedics, dermatology, and paediatrics. The company provides drugs in the form of tablets, softgels, injections, capsules, and syrups. … Read more